Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QNN8 | ISIN: CA88651M1086 | Ticker-Symbol: TOV0
Tradegate
20.01.25
16:32 Uhr
0,052 Euro
-0,011
-17,92 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
TIER ONE SILVER INC Chart 1 Jahr
5-Tage-Chart
TIER ONE SILVER INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0570,06314:34
0,0570,06312:50
ACCESS Newswire
404 Leser
Artikel bewerten:
(2)

Tier One Silver Inc.: Tier One Silver Engages Capital Markets and Corporate Communications Firms

Finanznachrichten News

VANCOUVER, BC / ACCESSWIRE / May 29, 2024 / Tier One Silver Inc. (TSXV:TSLV)(OTCQB:TSLVF) ("Tier One" or the "Company") is pleased to announce that it has engaged Strike Communications Inc. ("Strike") for corporate communications and capital markets support. Led by Julia Becker, Strike is a boutique capital markets, investor relations and corporate communications firm with extensive experience across various industries. In connection with the agreement, Strike will assist with the creation, coordination and implementation of the Company's targeted capital markets strategy and investor relations objectives.

Ms. Becker brings 15 years' experience in capital markets, corporate communications and business development. She has worked with many TSX and TSX Venture listed issuers across various industries, and with a boutique investment bank in Toronto. She has an extensive network of retail and institutional investors as well as investment banks and analysts across North America. Notably, Ms. Becker is Head, Investor Relations for Osino Resources (OSI)(OSIIF), which was recently sold to Yintai in an all-cash transaction for C$368 million.

The agreement has a one-year term, effective June 1, 2024, but may be terminated by either party upon 30 days' written notice. As compensation for its services, Strike will receive a monthly fee of C$8,500 and 300,000 options will be granted, subject to TSX Venture approval, exercisable at $0.30 for up to 5 years. The options will vest as to 25% on the date of grant and 12.5% every three months thereafter.

Peter Dembicki, CEO of Tier One commented, "We are excited to welcome Julia Becker to the Tier One Silver team to assist in introducing the Company to a broad network of industry experts, expanding our valued shareholder base, and establishing a strong capital markets strategy. It is an exciting time as we get closer to re-starting exploration at Curibaya and progress towards the next drilling campaign."

The Company also announces that it has engaged GRA Enterprises LLC DBA National Inflation Association ("GRA") to provide communications and media services to the Company for a term of six months commencing on May 21, 2024. GRA is a finance and media platform that provides information on the stock market. GRA will provide distribution and exposure of the Company's activities through email distribution lists, website hosting, and blog posts, as well as interviews and technical updates to build awareness of the Company. As consideration for the services to be provided under the GRA agreement, the Company will pay US$50,000. GRA does not currently own any interest, directly or indirectly, in the Company or its securities. GRA's head office operates in Mooresville, North Carolina.

The agreements with each of Strike and GRA are subject to customary TSX Venture Exchange acceptance.

About Tier One Silver

Tier One Silver is an exploration company focused on creating value for shareholders and stakeholders through the discovery of world-class silver, gold and copper deposits in Peru. The Company is focused on its flagship exploration project, Curibaya. The Company's management and technical teams have a strong track record in raising capital, discovery and monetization of exploration success. For more information, visit www.tieronesilver.com.

ON BEHALF OF THE BOARD OF DIRECTORS OF TIER ONE SILVER INC.

Peter Dembicki President, CEO and Director

For further information on Tier One Silver Inc., please contact the Company at (778) 729-0700 or info@tieronesilver.com.

Capital Markets Contact:
Julia Becker
Julia.becker@tieronesilver.com

Forward Looking Information and General Cautionary Language

This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, "forward-looking statements") that relate to the Company's current expectations and views of future events in connection with the Company's exploration plans. Forward-looking statements are not historical facts and therefore may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release, as related to future exploration plans, should not be heavily relied upon. These statements speak only as of the date of this news release.

Readers should refer to the risks discussed in the Company's Annual Information Form and Management's Discussion & Analysis for the year ended December 31, 2023, and subsequent continuous disclosure filings with the Canadian Securities Administrators available at www.sedarplus.ca.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Tier One Silver Inc.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.